More

    PhD Admissions Open at BRIC – RGCB | Apply Now

    PhD in Pharma: Admissions Open at BRIC – RGCB | Apply Now for Pharma Career

    If you are a research enthusiast and looking for a Pharma career, here is an exciting opportunity. BRIC–Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) has announced its PhD Admission for the January 2026 session, inviting applications from aspiring researchers in Biotechnology, Life Sciences, and Pharmacy. This program also offers excellent opportunities for graduates seeking a PhD in Pharma to advance their pharma career through research in Pharmaceutical and allied sciences. Affiliated with the Regional Centre for Biotechnology (RCB)—an Institution of National Importance under the Department of Biotechnology, Government of India—this prestigious PhD program provides state-of-the-art research facilities and interdisciplinary exposure. Candidates with a valid national fellowship (UGC/CSIR/ICMR/DBT/DST-INSPIRE) can apply online before November 14, 2025.

    Vacancies available for PhD Admissions – January 2026

    IMPORTANT DATES:

    • Last date for receiving the filled application: November 14, 2025
    • Date of Publication of the shortlisted candidates: November 18, 2025
    • Date of interview: December 15, 16 and 17, 2025
    • Date of joining Hostel: Before January 04, 2026
    • Commencement of the PhD program: January 05, 2026

    About BRIC-RGCB:

    The BRIC–Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) is one of India’s premier research institutions dedicated to advanced studies in biotechnology, life sciences, and pharmaceutical sciences. Functioning under the Department of Biotechnology (DBT), Government of India, BRIC-RGCB focuses on cutting-edge research in disease biology, molecular medicine, bioinformatics, and translational science. Affiliated with the Regional Centre for Biotechnology (RCB)—an Institution of National Importance established under the auspices of UNESCO—BRIC-RGCB offers a strong academic and research environment that nurtures innovation, interdisciplinary collaboration, and excellence. The institute provides world-class facilities, mentorship by leading scientists, and opportunities for research training and PhD in pharma, biotechnology, life sciences and related areas.

    Eligibility for PhD in Pharma Admission:

    • Candidates with a Post-graduate degree with a minimum of 60 % marks and 4-year Bachelor’s degree having a minimum of 75% marks in Life/ Agricultural/ Environmental/ Veterinary/ Pharmaceutical/ Medical Sciences or allied subjects Biochemistry/Biotechnology/ Bioinformatics/ Biophysics/ Chemistry/ Microbiology, etc.) marks in aggregate or equivalent grade in the UGC 10 point scale (or an equivalent grade in a point scale wherever grade system is followed) or an equivalent from a foreign educational institution accredited by an assessment and accreditation agency which is approved, recognized or authorized by an authority, established or incorporated under a law in its home country or any other statutory authority in that country which assess, accredit or assure quality and standard of the educational institutions are eligible to apply.
    • A relaxation of 5% of marks or an equivalent relaxation of grade point may be allowed for those candidates belonging to the SC, ST and differently abled candidates.
    • The candidate should have a valid JRF (UGC/ CSIR/ ICMR/ DBT/ DST-INSPIRE or any other nationally competitive fellowship) for 5 years offered by the Government.
    • The upper age limit should not exceed 26 years as of January 05, 2026.
    • The upper age limit for SC, ST, and differently abled candidates should not exceed 28 years as of January 05, 2026.
    • Candidates awaiting final results of their post graduate degree or 4-year Bachelor’s degree, and holding valid JRF (UGC/ CSIR/ ICMR/ DBT/ DST-INSPIRE or any other nationally competitive fellowship) for 5 years offered by the Government of India are eligible to apply. If selected, such candidates must produce their provisional / original certificates with eligible grades at the time of admission or as soon as it is issued.

    Selection Procedure:

    Candidates meeting all the eligibility criteria will be shortlisted for the interview. PhD interviews will be held only offline. Based on the performance of candidates in the personal interview scheduled at the RGCB Main Campus, Poojappura, applicants will be shortlisted for the final selection. The guidelines for interviews will be provided to all the shortlisted candidates. The list of the shortlisted candidates will be displayed on the RGCB notice board and website. The final selection will be based on the overall performance in the interview, laboratory rotation, and interaction with the faculty scientists. Apply Now and kickstart your pharma career.

    Application Procedure:

    • Only online applications will be accepted.
    • Application Fee (₹ 500) must be paid online using ‘SB Collect’ of State Bank of India through the URL given in the Payment Stage. SC/ ST/ EWS/ differently abled candidates are exempted from paying the processing fees subject to the submission of valid certificate.
    • The last date for receiving completed applications is 5 PM, November 14, 2025.
    • Incomplete applications or those without processing fees will be rejected.

    Fees for PhD Program:

    • Students admitted to PhD program will be required to pay an administrative fee of ₹5000 per semester for the first ten semesters, and ₹10,000 for subsequent semesters. Additionally all students have to pay the RCB administrative fees.

    Note:

    • All communications with candidates will be by email only.
    • You are requested to check the RGCB website for periodic updates.
    • In case of any application-related queries, contact: phd.admn@rgcb.res.in
    • The Interview will be conducted strictly in offline mode.

    CLICK HERE FOR ORIGINAL NOTIFICATION

    Related Articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Stay Connected

    42,522FansLike
    21,523FollowersFollow
    32,000SubscribersSubscribe
    - Advertisement -

    Latest Articles